LECHLEIDER ROBERT (Chief Medical Officer) sold 77.7% of their position (55K shares) of IMMUNOME INC. on the open market
Open‑market sale worth $1.24M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 7/7/2026ACC: 0001997584-26-000004
Officer· Chief Medical Officer
Since Oct 2023
-55K
Net shares
Net seller
$1.24M
Total sold
3
Open market trades
0B · 3S
5
Total transactions
55K acquired · 110K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+55K
Price / share
$8.73
Trade value
$480.15K
% of position
348.0%
7/2/2026
15.80K→70.81K
Common Stock
Direct
Shares
−22.71K
Price / share
$21.95
Trade value
$498.57K
% of position
32.1%
7/2/2026
70.81K→48.09K
Common Stock
Direct
Shares
−16.21K
Price / share
$22.76
Trade value
$369.03K
% of position
33.7%
7/2/2026
48.09K→31.88K
Common Stock
Direct
Shares
−16.07K
Price / share
$23.44
Trade value
$376.73K
% of position
50.4%
7/2/2026
31.88K→15.80K
Total
Net shares
+0.00
Net value
-$764.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/2/2026 | M · Option Exercise | +55K | $8.73 | $480.15K | 348.0% | 15.80K | 70.81K |
| Common Stock Direct | 7/2/2026 | S · Sale | −22.71K | $21.95 | $498.57K | 32.1% | 70.81K | 48.09K |
| Common Stock Direct | 7/2/2026 | S · Sale | −16.21K | $22.76 | $369.03K | 33.7% | 48.09K | 31.88K |
| Common Stock Direct | 7/2/2026 | S · Sale | −16.07K | $23.44 | $376.73K | 50.4% | 31.88K | 15.80K |
| Total | +0.00 | -$764.18K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
55K shares
Shares
−55K
Strike price
8.73
Held after
290K
Exercisable
—
7/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock55K shares | 7/2/2026 | M · Option Exercise | −55K | 8.73 | — | 290K |